Anaplasma marginale: differences in the virulence of two mexican isolates

Miguel Ángel García Ortiz; Ramón Aboytes Torres; Georgina Hernández Salgado; Germinal Jorge Cantó Alarcón; Sergio Darío Rodríguez Camarillo

2000, Number 2

<< Back Next >>

Vet Mex 2000; 31 (2)

Anaplasma marginale: differences in the virulence of two mexican isolates

García OMA, Aboytes TR, Hernández SG, Cantó AGJ, Rodríguez CSD

Full text

How to cite this article

Language: English/Spanish
References: 16
Page: 157-160
PDF size: 65.69 Kb.

ABSTRACT

The present work was designed to evaluate the virulence of Mexican Anaplasma marginale isolates MEX-15-099 (MEX15) and MEX-31-096 (MEX31). Two groups of four steers were inoculated with a dose of 1 × 106 infected erythrocytes of either of the isolates per animal. Experimental animals were monitored for 65 days from the inoculation date. Rectal temperature, packed cell volume (PCV), rickettsemia (PIE) and presence of specific antibodies detected by the ELISA, were registered. MEX15-infected steers reached maximal rickettsemia between 8.8% and 34.7%, while MEX31 steers only maximal values between 0.1% and 16.3%. Only MEX15 steers suffered fever › 40ºC coincidential with the amplification of the rickettsemia. A PCV loss of 68.2 ± 8.9% was registered for the MEX15 steers, which was statistically different (P‹ 0.05) to the 50.1 ± 8.9% loss registered for the MEX31 steers. Except for one MEX31 animal, all other animals developed O.D. readings between 0.355 and 0.829. Only the MEX15-infected animals presented clinical signs of anaplasmosis, whereas only one of the infected with the MEX31 isolate did. Under the conditions of this study, isolate MEX15 appeared more virulent than isolate MEX31.

REFERENCES

1. Ristic M. Anaplasmosis. In: Amstutz HI, editor. Bovine medicine and surgery. Vol 1. Sta. Barbara (Ca): American Veterinary Publications Inc, 1980:324-348.
2. Osorno BM, Ristic M. Anaplasmosis bovina con énfasis en control, diagnóstico, distribución de la enfermedad en México y uso de una vacuna atenuada de Anaplasma marginale. Vet Méx 1977;8:85-98.
3. Rodríguez-Camarillo SD, García-Ortiz MA, Cantó-Alarcón GJ, Hernández-Salgado G, Santos-Cerda N, Aboytes-Torres R. Ensayo de una vacuna experimental inactivada contra Anaplasma marginale. Téc Pecu Méx 1999;37;1-12.
4. Lotze JC. Variables and constants in bovine anaplasmosis and their relationship to chemotherapy. Am J Vet Res 1947;8:267-274.
5. Kuttler KL, Zaugg JL, Johnson LW. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates. Am J Vet Res 1984;45:2223-2226.
6. Alonso M, Blandino T, Sánchez A. Caracterización de cepas de Anaplasma marginale. Rvta Cub Cienc Vet 1989;20:71-78.
7. Gale KR, Leatch G, DeVos AJ, Jorgensen WK. Anaplasma marginale: effect of challenge of cattle with varying doses of infected erythrocytes. Int J Parasitol 1996;26:1417-1420.
8. McGuire TC, Palmer GH, Goff WL, Johnson MI, Davis WC. Common and isolate-restricted antigens of Anaplasma marginale detected with monoclonal antibodies. Infect Immun 1984;45:697-700.
9. Eriks IS, Stiller D, Goff WL, Panton M, Parish SM, McElwain TF, Palmer GH. Molecular and biological characterization of a newly isolated Anaplasma marginale strain. J Vet Diagn Invest 1994;6:435-441.
10. Goff WL, Winward LD. Detection of geographic isolates of Anaplasma marginale using polyclonal bovine antisera and microfluorometry. Am J Vet Res 1985;46:2399-2400.
11. García-Ortiz MA, Ángeles-Ojeda LE, Hernández-Salgado G, García-Tapia D, Aboytes-Torres R, Rodríguez-Camarillo SD. Caracterización de la virulencia de un aislado mexicano de Anaplasma marginale. Téc Pecu Méx 1998;36:197-202
12. Amerault TE, Roby TO. Preparation and characterization of a soluble Anaplasma marginale antigen. Am J Vet Res 1967;28:1067-1072.
13. Snedecor GW, Cochran WG. Statistical methods. Ames (Io): The Iowa State University Press, 1980.
14. Goff WL, Winward LD. Detection of geographic isolates of Anaplasma marginale, using polyclonal bovine antisera and microfluorometry. Am J Vet Res 1985;46:2399-2400.
15. Callow LL, Mellors LT. A new vaccine for Babesia argentina infection prepared in splenectomized calves. Austr Vet J 1966;42:464-465.
16. Vizcaino O, Carson CA, Lee A, Ristic M. Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia. Am J Vet Res 1978;39:229-233.